Search

Displaying results 5421 - 5430 of 7604 in total
  1. Drug

    Tolazamide

    go.drugbank.com/drugs/DB00839
    Approved

    A sulphonylurea hypoglycemic agent with actions and uses similar to those of chlorpropamide.

  2. Drug

    ISIS 325568

    go.drugbank.com/drugs/DB06099
    Investigational

    It was under investigation in clinical trial NCT00519727 (Safety Study of ISIS 325568 in Healthy Volunteers) for lowering blood glucose and helping control type 2 diabetes.

  3. Drug

    YSIL6

    go.drugbank.com/drugs/DB05017
    Experimental

    YSIL6 is a small-molecule drug in development for the treatment of inflammatory diseases, including rheumatoid arthritis and psoriasis.

  4. Drug

    5-Methoxy-N,N-diisopropyltryptamine

    go.drugbank.com/drugs/DB01441
    ExperimentalIllicit

    This substance is abused for its hallucinogenic effects.

    Categories: Heterocyclic Compounds with 4 or More Rings
  5. Drug

    SOT-107

    go.drugbank.com/drugs/DB05337
    Investigational

    This drug treat for a type of brain cancer called a high grade glioma brain tumour. About half of all brain tumours are gliomas.

  6. Drug

    DNB-001

    go.drugbank.com/drugs/DB05757
    Investigational

    DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma.

  7. Drug

    Etaracizumab

    go.drugbank.com/drugs/DB12213
    Investigational

    Etaracizumab has been investigated for the treatment of Psoriasis, Renal Cell Carcinoma, Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer, and Stage III Renal Cell Cancer.

  8. Drug

    ICG-136

    go.drugbank.com/drugs/DB17343
    Experimental

    It was investigated for the treatment of acute myeloid leukemia.

  9. Drug

    Mozafancogene autotemcel

    go.drugbank.com/drugs/DB17723
    Investigational

    RP-L102 is a lentiviral vector carrying the Fanconi Anemia-A (FANCA) gene currently being developed by Rocket Pharmaceuticals for the treatment of Fanconi anemia type A

  10. Drug

    Peldesine

    go.drugbank.com/drugs/DB02568
    Investigational

    It has undergone phase I trials for the treatment of Human Immunodeficiency Virus (HIV) infections.